Skip to content

ADPT

Adaptive Biotechnologies Corporation

NASDAQ · USHealthcareBiotechnology
$22.14-3.40%

Price as of Jul 20, 2026

ADPT ownership

Adaptive Biotechnologies Corporation ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
19
Net (3m)
-$21.1M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price -61.2%Institutions mixed (13F)
DateInsiderTypeSharesPrice
Jul 17, 2026LO FRANCISofficer: Chief People OfficerOption23,677$12.14
Jul 17, 2026LO FRANCISofficer: Chief People OfficerOption59,374$7.80
Jul 17, 2026LO FRANCISofficer: Chief People OfficerOption22,711$8.46
Jul 17, 2026LO FRANCISofficer: Chief People OfficerSell105,762$22.59
Jul 7, 2026ROBINS HARLAN Sofficer: Chief Scientific OfficerSell239,351$21.74
Jul 7, 2026ROBINS HARLAN Sofficer: Chief Scientific OfficerSell146,889$22.45
Jul 6, 2026BOBULSKY SUSANofficer: Chief Commercial Officer, MRDSell487$22.00
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption4,688$3.99
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption3,500$7.80
Jul 6, 2026LO FRANCISofficer: Chief People OfficerSell44,838$22.59
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption3,300$12.14
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption12,600$12.14
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption12,206$8.46
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption12,637$8.46
Jul 6, 2026LO FRANCISofficer: Chief People OfficerSell42,261$22.50
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption14,064$8.12
Jul 6, 2026LO FRANCISofficer: Chief People OfficerOption12,626$7.80
Jul 6, 2026LO FRANCISofficer: Chief People OfficerSell8,743$22.18
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedOption1,837$12.14
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedOption24,944$8.46
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedOption51,570$8.12
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedOption11,034$12.14
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedSell11,034$21.00
Jun 30, 2026BENZENO SHARONofficer: Chief Commercial Ofc Imm MedSell154,768$21.14
Jun 29, 2026BOBULSKY SUSANofficer: Chief Commercial Officer, MRDSell5,000$20.50
Jun 29, 2026GRIFFIN MICHELLE RENEEdirectorSell52,084$20.18
Jun 29, 2026GRIFFIN MICHELLE RENEEdirectorOption52,084$7.80
Jun 17, 2026ROBINS HARLAN Sofficer: Chief Scientific OfficerSell6,160$18.01
Jun 17, 2026ROBINS HARLAN Sofficer: Chief Scientific OfficerSell100,000$17.37
Jun 15, 2026BOBULSKY SUSANofficer: Chief Commercial Officer, MRDSell5,000$19.00

Source: ADPT SEC Form 4 filings, latest Jul 17, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their ADPT positions over the last 6 months (SEC Form 13F).

Increased
202
New positions
109
Reduced
190
Sold out
82
Largest moves
InstitutionActionSharesFiled
VIKING GLOBAL INVESTORS LPUnchanged30.0MFeb 17, 2026
VIKING GLOBAL INVESTORS LPUnchanged30.0MMay 15, 2026
BLACKROCK, INC.Reduced13.3MFeb 12, 2026
BLACKROCK, INC.Reduced13.3MMay 13, 2026
VANGUARD GROUP INCIncreased11.3MJan 29, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6.1MMay 15, 2026
WESTFIELD CAPITAL MANAGEMENT CO LPIncreased5.4MMay 11, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4.5MMay 8, 2026
INVESCO LTD.Increased4.5MMay 12, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased4.4MFeb 17, 2026
WESTFIELD CAPITAL MANAGEMENT CO LPNew Position4.1MFeb 11, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased3.9MMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased3.6MMay 15, 2026
LORD, ABBETT & CO. LLCIncreased3.5MMay 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased3.5MFeb 9, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.